awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37274132-94C13B5B-8226-413B-AA8F-38F07651C50C
Q37274132-94C13B5B-8226-413B-AA8F-38F07651C50C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37274132-94C13B5B-8226-413B-AA8F-38F07651C50C
Targeting the tumor microenvironment: from understanding pathways to effective clinical trials.
P2860
Q37274132-94C13B5B-8226-413B-AA8F-38F07651C50C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37274132-94C13B5B-8226-413B-AA8F-38F07651C50C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
00c75895af6f12d2cdbb9f27012dbc2f27e8f5aa
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.